U.S. markets closed

Summit Therapeutics Inc. (SMMT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
6.38-0.11 (-1.69%)
At close: 4:00PM EDT
Full screen
Loading interactive chart...
  • GlobeNewswire

    Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2021

    Cambridge, Massachusetts, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on its operational progress for the second quarter and six months ended June 30, 2021. Note: A glossary of terms is included at the end of this document in order to allow for the ease of understanding of terms or concepts used throughout this release. Financial Highlights Cash and cash equivalents on June

  • GlobeNewswire

    Summit Therapeutics Provides Update on Ri-CoDIFy Trials

    Cambridge, Massachusetts, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Based on a thorough review of the design and enrollment status of two ongoing blinded Phase III Ri-CoDIFy trials, Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that it will combine its two blinded pivotal Phase III clinical trials evaluating ridinilazole versus vancomycin into a single study. Ridinilazole, a novel first-in-class drug, is currently under investigation for use as first-line therapy for the treatment of initial a

  • PR Newswire

    Acurx Pharmaceuticals Joins the Antimicrobials Working Group

    The Antimicrobials Working Group (AWG) announced today the addition of Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (Acurx) to its coalition of companies with the mission to combat drug resistant infections and spur life-saving innovations. This new addition brings AWG's membership to 13 antimicrobial drug companies.